Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Novan Inc (NOVN)

Novan Inc (NOVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Novan Inc 4020 STIRRUP CREEK DRIVE SUITE 110 DURHAM NC 27703 USA

www.novantherapeutics.com P: 919-485-8080

Description:

Novan, Inc. is a pharmaceutical company. It engaged in the development and commercialization of therapies using its nitric oxide platform for dermatology. The Company's product candidates primarily include SB204, SB206, SB208 and SB414 which are in pre-clinical trial stage. It develops product through Nitricil technology(TM). Novan, Inc. is based in Durham, United States.

Key Statistics

Overview:

Market Capitalization, $K 2,636
Enterprise Value, $K -10,724
Shares Outstanding, K 28,015
Annual Sales, $ 23,680 K
Annual Net Income, $ -31,310 K
Last Quarter Sales, $ 3,170 K
Last Quarter Net Income, $ -14,120 K
60-Month Beta -0.06
% of Insider Shareholders 1.30%
% of Institutional Shareholders 14.51%
Float, K 27,651
% Float 98.70%
Short Volume Ratio 0.44

Growth:

1-Year Return -96.63%
3-Year Return -98.59%
5-Year Return -99.66%
5-Year Revenue Growth 1,006.54%
5-Year Earnings Growth 93.10%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.54 on 05/15/23
Next Earnings Date 08/10/23
Earnings Per Share ttm -1.50
EPS Growth vs. Prev Qtr -500.00%
EPS Growth vs. Prev Year 23.94%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 05/26/21

NOVN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -700.28%
Return-on-Assets % -39.58%
Profit Margin % -132.22%
Debt/Equity 0.00
Price/Sales 0.15
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.10
Interest Coverage -20.59
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar